Medicare Enrolled
Dr. Afshin Gabayan, M.D.
Hematology & Oncology · Beverly Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gabayan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gabayan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gabayan
Dr. Afshin Gabayan is a hematology & oncology specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gabayan performed 43,877 Medicare services across 3,847 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gabayan received a total of $42,526 from 89 pharmaceutical and/or device companies across 961 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gabayan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in CA
$42,526 industry payments
Medicare Practice Summary
Medicare Utilization ↗43,877
Medicare services
Top 17% in CA for hematology & oncology
3,847
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,309 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
30,000 | $1 | $8 |
| Denosumab injection (Prolia/Xgeva) | 3,181 | $14 | $104 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,212 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,079 | $8 | $60 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,048 | $10 | $150 |
| Anti-nausea injection (ondansetron/Zofran) | 873 | $0 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
696 | $8 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
503 | $146 | $1,135 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
480 | $6 | $47 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
371 | $7 | $56 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $102 | $848 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
324 | $19 | $147 |
| Iron level test | 277 | $6 | $50 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
276 | $13 | $173 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
227 | $5 | $37 |
| Free testosterone level test A blood test that measures the amount of free testosterone in your body. Free testosterone is the portion of the hormone not bound to proteins and available for use by tissues. |
207 | $25 | $198 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
199 | $27 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
193 | $12 | $112 |
| PSA test (prostate cancer screening) | 188 | $18 | $143 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
158 | $122 | $1,154 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
151 | $4 | $35 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
147 | $10 | $76 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
136 | $7 | $52 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
128 | $17 | $132 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
123 | $13 | $120 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
121 | $59 | $587 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
119 | $5 | $63 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
116 | $9 | $70 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
114 | $16 | $131 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $70 | $586 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
98 | $2 | $18 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
96 | $3 | $18 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
91 | $12 | $100 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 85 | $20 | $162 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
69 | $15 | $117 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
61 | $30 | $310 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
54 | $14 | $132 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
45 | $1 | $5 |
| New patient office visit, complex (60-74 min) | 42 | $184 | $1,477 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $15 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
25 | $1 | $10 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
21 | $1 | $9 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
20 | $12 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $127 | $1,271 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
69.9% high complexity
13.0% medium
17.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$42,526
Total received (2018-2024)
Avg $6,075/year across 7 years
Top 13% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
961
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,829 (46.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,705 (44.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,993 (9.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,291
2023
$6,144
2022
$8,498
2021
$11,988
2020
$2,807
2019
$3,187
2018
$3,612
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$3,973
AstraZeneca Pharmaceuticals LP
$535
Daiichi Sankyo Inc.
$252
SUN PHARMACEUTICAL INDUSTRIES INC.
$178
Lilly USA, LLC
$115
ABBVIE INC.
$112
Incyte Corporation
$104
Gilead Sciences, Inc.
$104
Genmab U.S., Inc.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$99
Janssen Biotech, Inc.
$82
Bayer Healthcare Pharmaceuticals Inc.
$78
Dendreon Pharmaceuticals LLC
$56
Regeneron Healthcare Solutions, Inc.
$53
Tempus AI, Inc
$48
Secura Bio, Inc.
$43
Spectrum Pharmaceuticals Inc.
$30
Amneal Pharmaceuticals LLC
$27
TerSera Therapeutics LLC
$26
TAIHO ONCOLOGY, INC.
$26
SpringWorks Therapeutics, Inc.
$25
Merck Sharp & Dohme LLC
$25
JAZZ PHARMACEUTICALS INC.
$24
Sumitomo Pharma America, Inc.
$23
SOBI, INC
$22
Stemline Therapeutics Inc.
$21
ADC Therapeutics America, Inc.
$21
Telix Pharmaceuticals
$20
Genentech USA, Inc.
$19
Novartis Pharmaceuticals Corporation
$19
HEARTFLOW, INC.
$17
Acrotech Biopharma Inc.
$14
Top 3 companies account for 75.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$8,311
Takeda Pharmaceuticals U.S.A., Inc.
$4,118
Kite Pharma, Inc.
$3,521
AstraZeneca Pharmaceuticals LP
$2,152
GENZYME CORPORATION
$1,763
Janssen Scientific Affairs, LLC
$1,755
BeiGene USA, Inc.
$1,678
Seagen Inc.
$1,503
Janssen Global Services, LLC
$1,500
Veloxis Pharmaceuticals, Inc.
$1,254
Genentech USA, Inc.
$993
Amgen Inc.
$883
Novartis Pharmaceuticals Corporation
$863
Daiichi Sankyo Inc.
$804
Janssen Biotech, Inc.
$800
Pharmacyclics LLC, An AbbVie Company
$708
Bayer HealthCare Pharmaceuticals Inc.
$664
Incyte Corporation
$582
Merck Sharp & Dohme Corporation
$467
Ipsen Biopharmaceuticals, Inc
$422
E.R. Squibb & Sons, L.L.C.
$380
Gilead Sciences, Inc.
$344
Celgene Corporation
$343
Regeneron Healthcare Solutions, Inc.
$324
Astellas Pharma US Inc
$286
ABBVIE INC.
$263
Lilly USA, LLC
$262
Teva Pharmaceuticals USA, Inc.
$262
EMD Serono, Inc.
$214
Eisai Inc.
$200
Foundation Medicine, Inc.
$194
SUN PHARMACEUTICAL INDUSTRIES INC.
$178
Genentech, Inc.
$177
Pharmacyclics LLC, an AbbVie Company
$175
PUMA BIOTECHNOLOGY, INC.
$168
Novocure Inc.
$166
Exelixis Inc.
$159
Clovis Oncology, Inc.
$156
Bayer Healthcare Pharmaceuticals Inc.
$153
Mirati Therapeutics, Inc.
$150
MENARINI SILICON BIOSYSTEMS, INC.
$145
Dendreon Pharmaceuticals LLC
$144
TG THERAPEUTICS, INC.
$140
Puma Biotechnology, Inc.
$139
Taiho Oncology, Inc.
$135
TerSera Therapeutics LLC
$134
Merck Sharp & Dohme LLC
$130
Global Blood Therapeutics, Inc.
$123
Karyopharm Therapeutics Inc.
$118
Seattle Genetics, Inc.
$118
Alexion Pharmaceuticals, Inc.
$111
Blueprint Medicines Corporation
$110
Stemline Therapeutics Inc.
$101
Genmab U.S., Inc.
$100
EISAI INC.
$97
AVEO Pharmaceuticals, Inc.
$96
MorphoSys, US Inc.
$96
Sun Pharmaceutical Industries Inc.
$94
TESARO, Inc.
$80
Acrotech Biopharma LLC
$72
JAZZ PHARMACEUTICALS INC.
$66
TAIHO ONCOLOGY, INC.
$54
TOLMAR Pharmaceuticals, Inc.
$49
Tempus AI, Inc
$48
Sumitomo Pharma America, Inc.
$46
CTI BioPharma Corp.
$45
Myovant Sciences Inc.
$45
GlaxoSmithKline, LLC.
$44
MEDIVATION FIELD SOLUTIONS LLC
$44
Secura Bio, Inc.
$43
Heron Therapeutics, Inc.
$41
G1 Therapeutics, Inc.
$40
Spectrum Pharmaceuticals Inc.
$30
INSYS Therapeutics Inc
$30
Amneal Pharmaceuticals LLC
$27
ARRAY BIOPHARMA INC
$26
Myriad Genetic Laboratories, Inc.
$26
SpringWorks Therapeutics, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$24
Aveo Pharmaceuticals, Inc.
$24
Rigel Pharmaceuticals, Inc.
$23
SOBI, INC
$22
GE HealthCare
$22
ADC Therapeutics America, Inc.
$21
Telix Pharmaceuticals
$20
Dova Pharmaceuticals
$18
Helsinn Therapeutics (U.S.), Inc.
$17
HEARTFLOW, INC.
$17
Acrotech Biopharma Inc.
$14
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cellsearch · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · EXKIVITY · Enhertu · Epkinly · Erleada · FASLODEX · FFRct · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GAVRETO · GAZYVA · Halaven · Herceptin · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OGSIVEO · OPDIVO · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Prolia · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (47%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
393
Per 100K population
4.0
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi
0.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gabayan is a mixed practice specialist, with above-average Medicare volume (top 17% in CA), with mixed engagement industry engagement in the top 13% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gabayan experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Gabayan performed 30,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gabayan receive payments from pharmaceutical companies?
Yes. Dr. Gabayan received a total of $42,526 from 89 companies across 961 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gabayan's costs compare to other hematology & oncology specialists in Beverly Hills?
Dr. Gabayan's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gabayan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Beverly Hills
Browse hematology & oncology specialists in Beverly Hills ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology